Install
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
- 94articles · 30d
- 1+ day agolatest article
- Aug 17, 2026earliest in window
- 95%with images
- 86avg words
- health 56
- business 43
- biotech 35
- fda 28
- pharma 28
- biotechnology 26
- cancer 21
- drug development 21
- clinical trials 19
- type-newspost 19
- tmt newswire 16
- globenewswire 15
- pharmaceuticals 15
- stat+ 15
- biopharma 13
- markets 13
- oncology 13
- (midwest communications 12
- artificial intelligence 12
- business & health 11
- Health & Wellness 74
- Medical 63
- Science & Technology 31
- Health 30
- Economy, Business & Finance 27
- Finance & Business 21
- Business & Industrial 15
- Science & Nature 7
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Encoded closes $275M Series F for Dravet syndrome drug
4+ day, 19+ hour ago (75+ words) Endpoints News Encoded closes $275M Series F for Dravet syndrome drug Encoded Therapeutics has tacked on $275 million in new capital, closing a Series F round led…...
ARPA-H selects companies to build AI tools for heart disease
4+ day, 19+ hour ago (76+ words) Endpoints News ARPA-H selects companies to build AI tools for heart disease UpDoc, Tempus AI and Atman Health will participate in a new program that aims to build FDA-au…...
Kura Oncology spins out diabetes pipeline with $50M and Lilly's help
5+ day, 1+ hour ago (79+ words) Kura Oncology spins out diabetes pipeline with $50M and Lilly’s help Endpoints News Kura Oncology spins out diabetes pipeline with $50M and Lilly's help Kura Oncology, the maker of the…...
Pharvaris' stock jumps on pivotal success in rare genetic disease
5+ day, 18+ hour ago (157+ words) Pharvaris’ stock jumps on pivotal success in rare genetic disease Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these…...
Moonwalk raises $70M to test siRNA treatment for obesity
6+ day, 49+ min ago (75+ words) Endpoints News Moonwalk raises $70M to test siRNA treatment for obesity Moonwalk Biosciences is heading to the clinic with an obesity program and has raised $70 million for…...
Diabetes cell therapy biotechs Sernova and Seraxis to merge
6+ day, 1+ hour ago (79+ words) Endpoints News Diabetes cell therapy biotechs Sernova and Seraxis to merge Two companies that have spent decades trying to develop cell therapies for dia…...
Roivant reports Phase 2 win for lung disease drug that it got from Bayer
6+ day, 2+ hour ago (151+ words) #ERS26: Roivant reports Phase 2 win for lung disease drug that it got from Bayer Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt…...
AbbVie-allied ADARx aims to go public with 3 drugs in the clinic
1+ week, 2+ day ago (90+ words) Endpoints News AbbVie-allied ADARx aims to go public with 3 drugs in the clinic RNA interference company ADARx Pharmaceuticals revealed its intentions to go…...
ARPA-H awards $125M for manufacturing custom RNA therapies on demand
1+ week, 5+ day ago (84+ words) Endpoints News ARPA-H awards $125M for manufacturing custom RNA therapies on demand The dream of making personalized genetic medicines at a moment’s notice…...
Three takeaways from the latest White House drug pricing event
1+ week, 5+ day ago (78+ words) Endpoints News Three takeaways from the latest White House drug pricing event President Donald Trump announced voluntary drug pricing deals with nine new companies on Monday, for…...